Emerging Therapies Expand Options in Lung Cancer
Emerging Therapies Expand Options in Lung Cancer
Source : https://www.onclive.com/view/emerging-therapies-expand-options-in-lung-cancer
During the past 12 months, the treatment landscape for patients with non-small cell lung cancer has expanded dramatically with FDA approvals of the first drugs directed at KRAS G12C and EGFR exon 20 mutations as well as continued progress in developing new therapies for subsets of patients with other molecularly targetable alterations and with PD-L1-high disease.